Marksans Pharma LimitedNSE: MARKSANS

Press Release Nov 22 2024

Nov 22, 2024 at 5:03 PM UTC

Marksans Pharma Limited has informed the Exchange regarding a press release dated November 22, 2024, titled "USFDA approval for Loratadine USP 10mg tablets".

View Attachment